Sector portfolio · Private equity · United States

Foresite Capital's Biotech portfolio

Foresite Capital has backed 68 Biotech startups in rounds we track, $13B between them, shown by the stage each has reached. The best-funded is Intarcia Therapeutics.

68startups backed
6stages
$13Braised between them
Series C and laterbiggest stage

Foresite Capital's whole portfolioForesite Capital's profile

Series C and later

20

Stage not reported

18

Series B

16

Series A

9

Pre-seed and seed

3

Growth

2

Segment by segment

Series C and later

20 startups · $4.6B raised

  1. Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.United States$932M
  2. Arcus BiosciencesArcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.United States$427M
  3. Orchard TherapeuticsOrchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.United Kingdom$377M
  4. Eikon TherapeuticsEikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.United States$351M
  5. Solid BiosciencesSolid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.United States$333M
  6. bit.biobit.bio is a synthetic biology and cell programming company based in Cambridge, United Kingdom.United Kingdom$264M
  7. LifeMine TherapeuticsLifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.United States$230M
  8. AlectorAlector is a biopharmaceutical company that develops therapies for the treatment of neurodegeneration diseases.United States$215M

Stage not reported

18 startups · $2.7B raised

  1. TPTurning Point TherapeuticsTurning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.-$460M
  2. AlumisAlumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.United States$345M
  3. Nurix TherapeuticsNurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.United States$250M
  4. Rapt TherapeuticsRapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.United States$250M
  5. CG OncologyCG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.United States$238M
  6. 10X Genomics10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.United States$215M
  7. IInscriptaUnited States$205M
  8. AtaiBeckleyAtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.Germany$150M

Series B

16 startups · $2.6B raised

  1. Intellia TherapeuticsIntellia Therapeutics is a genome editing company that develops curative gene-editing treatments.United States$485M
  2. Wave Life SciencesWave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling United States$434M
  3. Beam TherapeuticsBeam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.United States$322M
  4. Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.United States$310M
  5. Generation BioGeneration Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.United States$176M
  6. Keros TherapeuticsKeros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.United States$163M
  7. PharvarisPharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.Switzerland$132M
  8. JJuvenescenceIreland$126M

Series A

9 startups · $1.5B raised

  1. Tango TherapeuticsTango Therapeutics is a biotechnology company that is developing next generation cancer therapies.United States$852M
  2. GTGemini TherapeuticsGemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.United States$138M
  3. Slate MedicinesSlate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.United States$130M
  4. RayTheraRayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.United States$110M
  5. Nested TherapeuticsNested Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$90M
  6. VeliaVelia is a biotech company that discovers and develops the therapeutic potential of human proteins.United States$55M
  7. Third Arc BioThird Arc Bio is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, founded in 2022.United States$52M
  8. Spear BioSpear Bio is a biotechnology startup based in Woburn, Massachusetts, founded in 2021.United States$45M

Pre-seed and seed

3 startups · $30M raised

  1. IndomoIndomo is a clinical-stage therapeutics company based in San Francisco, California, focused on developing innovative treatments foUnited States$25M
  2. TempestTempest is a Celtic rock band based in the San Francisco Bay Area, active since 1988.United States$3.2M
  3. SutroSutro, Inc.United States$2.2M

Growth

2 startups · $1.3B raised

  1. Intarcia TherapeuticsIntarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.United States$1.1B
  2. Element BiosciencesElement Biosciences is a biotechnology company based in San Diego, founded in 2017 by former Illumina scientists.United States$190M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Foresite Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioForesite Capital's Pharma portfolio12 startups · $2.2BSector portfolioForesite Capital's Healthtech portfolio10 startups · $973MPortfolio mapForesite Capital portfolio map91 startups · $17BCo-investorsWho invests with Foresite Capital77 co-investorsSector portfolioRA Capital Management's Biotech portfolio197 startups · $38BSector portfolioOrbiMed's Biotech portfolio176 startups · $28B

Raising from investors like Foresite Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps